Healthcare Data Collection Consent Template¶

Important Notice¶

This is an informational template only. All actual data collection must use Institutional Review Board (IRB)-approved consent forms specific to your research protocol. This template provides general guidance on required elements for healthcare data consent.

Study Purpose and Procedures¶

Clear explanation of the research objectives and data collection methods:

Research Purpose: Detailed description of study goals and scientific rationale
Data Collection Methods: Specific procedures for data gathering and processing
Duration of Participation: Time commitment required from participants
Frequency of Data Collection: How often data will be collected and for how long
Data Types: Specific categories of health information to be collected

Risks and Benefits Assessment¶

Comprehensive evaluation of potential risks and anticipated benefits:

Potential Risks:
Privacy risks associated with data collection and storage
Potential for re-identification despite de-identification measures
Emotional or psychological impact of study participation
Time burden and inconvenience of participation
Potential impact on future healthcare or insurance
Anticipated Benefits:
Direct benefits to individual participants (if any)
Broader benefits to healthcare and medical knowledge
Contribution to improved treatments or care practices
Advancement of medical research in relevant field

Privacy Protections and Data Security¶

Detailed safeguards to protect participant privacy and data confidentiality:

De-identification Procedures: Methods used to remove personally identifiable information
Data Security Measures: Encryption, access controls, and secure storage protocols
Data Sharing Restrictions: Limitations on data sharing with third parties
Retention Policies: How long data will be stored and when it will be destroyed
Access Limitations: Who will have access to the data and under what circumstances

Voluntary Participation Rights¶

Clear explanation of participant rights and withdrawal options:

Voluntary Nature: Participation is completely voluntary with no penalties for refusal
Right to Withdraw: Participants can withdraw at any time without consequence
Withdrawal Process: How to withdraw and what happens to already collected data
Partial Withdrawal: Option to withdraw specific types of data while continuing participation
Contact Information: Clear instructions for exercising withdrawal rights

Contact Information and Support¶

Accessible communication channels for questions and concerns:

Principal Investigator: Name, title, and direct contact information
Study Coordinator: Primary point of contact for day-to-day questions
Institutional Contact: IRB or research administration contact for concerns
Emergency Contacts: 24/7 support for urgent issues or adverse events
Support Resources: Available counseling or support services

# Informed Consent Form Template

**Study Title**: [Full study title as registered with IRB]

**Principal Investigator**: [Name, credentials, institutional affiliation]

**Protocol Number**: [IRB-assigned protocol number]

**Version Date**: [Date of current consent version]

---

## Purpose of the Research

You are being asked to participate in a research study conducted by [Institution/Organization]. The purpose of this study is to [clear, concise description of research objectives and goals].

This study will involve [brief description of study procedures and data collection methods]. Your participation will require approximately [time commitment] over a period of [study duration].

---

## Study Procedures

If you agree to participate, you will be asked to:

1. **Data Collection**: [Specific data to be collected, e.g., "Provide access to your electronic health records from the past 5 years"]

2. **Questionnaires/Surveys**: [Description of any surveys or questionnaires to be completed]

3. **Follow-up**: [Description of any follow-up data collection or contact]

4. **Data Analysis**: [How collected data will be analyzed and used]

---

## Potential Risks

Participation in this study may involve the following risks:

- **Privacy Risk**: Despite de-identification efforts, there is a small risk that your information could be re-identified
- **Data Breach**: Potential for unauthorized access to health information
- **Emotional Impact**: [Any psychological or emotional risks specific to the study]
- **Time Burden**: [Time commitment and potential inconvenience]

We have implemented the following measures to minimize these risks:

- All data will be de-identified using [specific de-identification methods]
- Data will be encrypted and stored on secure, U.S.-based servers
- Access to data will be limited to authorized research personnel only
- Regular security audits and compliance monitoring

---

## Potential Benefits

Participation in this study may provide the following benefits:

- **Individual Benefits**: [Direct benefits to participants, if any]
- **Broader Impact**: Your participation will contribute to [describe scientific or medical advancement]
- **Healthcare Improvement**: Findings may lead to improved [treatments, diagnostics, care practices]

---

## Privacy and Confidentiality

Your privacy and the confidentiality of your information are of utmost importance:

- **De-identification**: All personal identifiers will be removed from your data using [specific methods]
- **Data Security**: Your information will be protected using [encryption, access controls, secure storage]
- **Data Storage**: All data will be stored in U.S.-based facilities compliant with HIPAA regulations
- **Data Sharing**: De-identified data may be shared with [describe any data sharing plans]
- **Retention Period**: Data will be retained for [X years] after study completion, then securely destroyed

---

## Voluntary Participation

Your participation in this study is completely voluntary:

- You may refuse to participate without any penalty or loss of benefits
- You may withdraw from the study at any time without penalty
- If you withdraw, you may request that your data be removed from the study
- Your decision to participate or withdraw will not affect your healthcare or relationship with [institution]

---

## Costs and Compensation

- **Costs**: There are no costs to you for participating in this study
- **Compensation**: [Describe any compensation, reimbursement, or incentives]
- **Expenses**: [Any expenses that will be covered or reimbursed]

---

## Questions and Concerns

If you have any questions about this study, please contact:

**Principal Investigator**:

- Name: [PI Name, credentials]
- Phone: [Phone number]
- Email: [Email address]
- Office Address: [Physical address]

**Study Coordinator**:

- Name: [Coordinator name]
- Phone: [Phone number]
- Email: [Email address]

**IRB Contact**:

- Institution: [IRB institution name]
- Phone: [IRB contact phone]
- Email: [IRB contact email]

For questions about your rights as a research participant, contact the [Institution] Institutional Review Board at [IRB contact information].

---

## Consent Statement

By signing below, I confirm that:

1. I have read and understood this consent form
2. I have had the opportunity to ask questions and have them answered
3. I understand that participation is voluntary
4. I understand I can withdraw at any time
5. I agree to participate in this research study

**Participant Signature**: ************\_\_\_************ Date: **\_\_\_\_**

**Printed Name**: ****************\_\_****************

**Witness Signature** (if required): ********\_******** Date: **\_\_\_\_**

**Person Obtaining Consent**: **********\_\_********** Date: **\_\_\_\_**

Digital Health Data Collection¶

For studies involving wearable devices, mobile apps, or other digital health technologies:

Device Usage: Clear explanation of how devices will be used and monitored
Data Streams: Specific types of data collected (heart rate, activity, location, etc.)
Battery/Privacy Impact: Effects on device battery life and privacy implications
Data Ownership: Clarification of who owns the collected data
Technical Support: How technical issues will be addressed

Genetic/Genomic Data¶

For studies involving genetic or genomic information:

Genetic Privacy: Special considerations for genetic data sensitivity
Family Implications: Potential impact on blood relatives
Future Use: How genetic data might be used in future research
Commercialization: Disclosure of any commercial interests
Genetic Counseling: Access to genetic counseling if needed

Long-term Follow-up Studies¶

For longitudinal or follow-up studies:

Contact Methods: How participants will be contacted for follow-up
Tracking Changes: How researchers will handle changes in contact information
Interim Results: Whether interim findings will be shared with participants
Study Continuation: Plans if the original research team changes

Regulatory Compliance Requirements¶

HIPAA Authorization Elements¶

When PHI is involved, include HIPAA-specific authorization:

HIPAA Privacy Rule Compliance: Specific authorization for PHI use in research
PHI Description: Exact description of PHI to be used/disclosed
Purpose: Research purpose for PHI use
Expiration: When authorization expires
Revocation: Right to revoke authorization

Common Rule Compliance¶

Ensure compliance with 45 CFR Part 46 (Federal Policy for Protection of Human Subjects):

IRB Review: Protocol must be reviewed and approved by an IRB
Informed Consent: All required elements must be included
Vulnerable Populations: Additional protections for vulnerable groups
Continuing Review: Ongoing IRB oversight requirements

Required Documentation¶

Signed Consent Form: Original signed by participant and researcher
Consent Process Notes: Documentation of consent discussion
Information Sheets: Any supplemental information provided
Contact Information: Updated contact information for participant
Version Control: Record of consent form version used

For digital consent processes:

Platform Security: Secure, auditable electronic signature platform
Accessibility: Ensure consent platform is accessible to all participants
Audit Trail: Complete record of consent process and interactions
Backup Documentation: Paper backup options for technical failures

Withdrawal and Data Handling¶

Withdrawal Procedures¶

Verbal Withdrawal: Accept verbal withdrawal requests
Written Confirmation: Follow up verbal requests with written confirmation
Partial Withdrawal: Allow withdrawal of specific data types
Data Removal: Process for removing withdrawn participant data
Notification: Inform participant of data removal completion

Data Handling Post-Withdrawal¶

Immediate Cessation: Stop all new data collection upon withdrawal
Data Removal: Remove participant's data from active datasets
Archival Retention: May retain minimal data for regulatory compliance
Re-contact Prohibition: Do not re-contact withdrawn participants
Future Use Restriction: Cannot use withdrawn participant data in future analyses

Language and Accessibility¶

Plain Language Requirements¶

Use clear, non-technical language understandable to general audience
Avoid medical jargon or explain technical terms
Short sentences and paragraphs for readability
Active voice and direct address ("you will be asked")

Accessibility Considerations¶

Large Print: Available in large print for visually impaired
Audio Recording: Provide audio version of consent form
Translation Services: Professional translation for non-English speakers
Literacy Support: Reader services for participants with low literacy
Cognitive Support: Simplified versions for participants with cognitive impairments

Protocol Modifications¶

Minor Changes: May not require re-consent if risk/benefit ratio unchanged
Major Changes: Require re-consent with updated consent form
New Information: Promptly inform participants of new relevant information
Continuing Review: Annual IRB review and approval maintenance

Increased Risk: Any increase in study risks
New Procedures: Addition of new study procedures
Extended Duration: Significant extension of study timeline
New Data Types: Collection of additional data types
Regulatory Changes: Changes in applicable laws or regulations

Emergency and Adverse Event Procedures¶

Adverse Event Reporting¶

Definition: Any unfavorable medical occurrence during study participation
Reporting Timeline: Immediate reporting to IRB and sponsor
Participant Notification: Inform participants of relevant adverse events
Safety Monitoring: Data Safety Monitoring Board oversight (if applicable)

Emergency Contact Procedures¶

24/7 Support: Emergency contact information for urgent issues
Medical Emergency: Protocol for handling medical emergencies
Study-Related Injury: Compensation and treatment for study-related injuries
Crisis Intervention: Mental health support for psychological distress

Quality Assurance and Training¶

Researcher Training: All study personnel trained in consent procedures
Competency Assessment: Regular assessment of consent administration skills
Cultural Competency: Training in cultural sensitivity and diverse populations
Documentation Training: Proper documentation of consent process

Quality Control Measures¶

Consent Audits: Regular audits of consent documentation
Process Monitoring: Ongoing monitoring of consent procedures
Participant Feedback: Surveys to assess consent process effectiveness
Continuous Improvement: Regular updates to consent processes based on feedback

Legal and Ethical Considerations¶

Legal Requirements by Jurisdiction¶

Federal Regulations: 45 CFR Part 46 (Common Rule), 21 CFR Parts 50, 56 (FDA)
State Laws: Additional state-specific requirements for research consent
International Standards: If applicable, compliance with Declaration of Helsinki
Tribal Requirements: Special considerations for research with tribal populations

Ethical Principles¶

Respect for Persons: Autonomy and protection of vulnerable populations
Beneficence: Maximizing benefits and minimizing harms
Justice: Fair distribution of research burdens and benefits
Transparency: Open communication about study goals and procedures

This consent template provides comprehensive guidance for developing IRB-approved consent forms for healthcare data collection. All actual consent forms must be reviewed and approved by an Institutional Review Board before use.

Last Updated: 9/28/2025 Version: 1.0.0